MASHINIi

ReShape Lifesciences, Inc..

RSLS.US | Manufacture of medical and dental instruments and supplies

ReShape Lifesciences Inc. is a medical technology company focused on developing and commercializing innovative solutions for weight loss and metabolic health. The company's primary product is the ReShape Vest, an investigational, minimally invasive, laparoscopically implanted medical device intended...Show More

Ethical Profile

Mixed.

ReShape Lifesciences, Inc. (RSLS.US) presents a mixed ethical profile. While the company has a stated target of 7% annual waste reduction, reports suggest it achieved a 2.3% year-over-year reduction in waste diversion from landfill. Only 42% of its product components are recyclable, falling short of the industry's 65% target by 2025. The safe disposal rate for hazardous waste is 87%, below the 95% industry compliance target. Data on packaging sustainability, recycled content, and other environmental initiatives is not available. Furthermore, information regarding fair pay, worker respect, ethical sourcing, and honest business practices is largely insufficient for a comprehensive assessment. The company reported 31 employees in 2023, with CEO compensation at US$324,000.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business-30
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products-40
-100100

Better Health for All

0

No specific, concrete data points were found in the provided articles to assess ReShape Lifesciences, Inc. against any of the 'Better Health for All' KPIs. All provided article links were either inaccessible, returned 404 errors, or explicitly stated a lack of relevant data for the company and value.

Fair Money & Economic Opportunity

0

No evidence available to assess ReShape Lifesciences, Inc. on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

0

The company reported that 0% of its workforce is covered by collective bargaining agreements.

1
Given the absence of evidence regarding active union-busting tactics or other negative actions, and the presence of a workforce, this KPI is scored as N/A, as there is no unionized workforce to assess for coverage. No specific data points were provided for living wage coverage, CEO to median pay ratio, safety incident rate, pay equity, worker engagement, turnover rate, labor violation incidents, insecure contract share, or health insurance coverage.
2

Fair Trade & Ethical Sourcing

0

No evidence available to assess ReShape Lifesciences, Inc. on Fair Trade & Ethical Sourcing.

Honest & Fair Business

0

No specific, concrete data points were found across the provided articles for any of the 'Honest & Fair Business' KPIs, including regulatory fines, transparency index scores, whistleblower policies, financial restatements, audit coverage, ESG controversy scores, complaint resolution times, board conflict-free percentages, anti-corruption policies, or third-party verification.

1
While the company is noted to file SEC reports (10K, 10Q, 8K) and has annual reports available from 2007-2024, and its reports received a usefulness score of 4.8/5.0, no quantitative or qualitative evidence directly addressing the rubric's specific metrics was present.
2

Kind to Animals

0

ReShape Lifesciences conducts animal testing, including preclinical studies using a type 2 diabetic porcine animal model for its neuromodulation device

1
and animal studies for the Lap-Band System Calibration Tube to establish substantial equivalence, usability, safety, and effectiveness.
2
However, the provided articles do not offer specific data on the number of animals used annually, the company's formal animal testing policy, the ethical practices of its animal agriculture sourcing, its participation in animal-free R&D collaborations, or its engagement in public policy advocacy for animal welfare. Therefore, these KPIs cannot be scored.

No War, No Weapons

0

ReShape Lifesciences is a medical technology company focused on weight loss and metabolic health solutions. The company's products, including STIMEL-03 and Lap-Band 2.0 FLEX, are medical devices.

1
ReShape Lifesciences has an exclusive distribution agreement to provide these medical devices to U.S. Veterans and Active-Duty Service Members through the VA and DoD systems.
2
This activity is consistently described as unrelated to arms sales, conflict, or peacebuilding, and the company's core business does not involve defense or arms-related activities. There is no evidence of revenue derived from arms or defense contracts, no development or sale of dual-use products, no defense business requiring board oversight or divestment, no exposure to controversial weapons, and no investment in peace technology versus military technology.
3

Planet-Friendly Business

-30

ReShape Lifesciences has no mentioned regulatory actions, violations, fines, or compliance issues in the provided articles for the year ended December 31, 2024, or in other summaries.

1
The company also achieved EU MDR and UKCA certifications for its medical devices ahead of the 2027 deadline, demonstrating compliance with stricter European standards for product safety.
2

Respect for Cultures & Communities

0

No evidence available to assess ReShape Lifesciences, Inc. on Respect for Cultures & Communities.

Safe & Smart Tech

0

No evidence available to assess ReShape Lifesciences, Inc. on Safe & Smart Tech.

Zero Waste & Sustainable Products

-40

ReShape Lifesciences currently has 42% of its product components recyclable.

1
For hazardous waste management, the company reports an 87% safe disposal rate, which is below the industry's 95% compliance requirement.
2

Own ReShape Lifesciences, Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.